KATHERINE ATKINSON: Open Payments
NPI 1700849643 · AMHERST, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$603 in 17 payments from 13 companies in 2025. Trend: 2023 $1,031 · 2024 $449 · 2025 $603
Food & beverage: $603
| Company | Payments | Amount |
|---|---|---|
| Paragonix Technologies, Inc. | 1 | $124 |
| Lilly USA, LLC | 1 | $114 |
| ABBVIE INC. | 3 | $82 |
| Astellas Pharma US Inc | 2 | $65 |
| E.R. Squibb & Sons, L.L.C. | 2 | $41 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $34 |
| Radius Health, Inc. | 1 | $27 |
| Indivior Inc. | 1 | $25 |
| TOLMAR, INC. | 1 | $22 |
| Amgen Inc. | 1 | $22 |
Products named: BaroGuard, KISUNLA, Veozah, VRAYLAR, Kerendia, Tymlos, CAMZYOS, SUBLOCADE.
Industry payments across MA — which companies pay providers there.
